Biocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the Indian drugmaker. This stake sale represents 5.64% of Biocon’s outstanding shares. The offer’s floor price was set at a discount to the previous closing price. Block deals totaling nearly nine crore shares occurred in early trading hours.
GAIL shares jump 4% as Q2 net profit rises over 8% to Rs 4,650 crore, revenue grows 17%
GAIL shares rose nearly 4% after the company reported strong second-quarter profit and revenue growth, supported by its gas marketing and transmission businesses. Investor sentiment